These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36184602)

  • 1. Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria.
    Tarning J; von Seidlein L; Dondorp AM; White NJ; Maude RJ
    BMC Res Notes; 2022 Oct; 15(1):313. PubMed ID: 36184602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
    Tripura R; von Seidlein L; Sovannaroth S; Peto TJ; Callery JJ; Sokha M; Ean M; Heng C; Conradis-Jansen F; Madmanee W; Peerawaranun P; Waithira N; Khonputsa P; Jongdeepaisal M; Pongsoipetch K; Chotthanawathit P; Soviet U; Pell C; Duanguppama J; Rekol H; Tarning J; Imwong M; Mukaka M; White NJ; Dondorp AM; Maude RJ
    Lancet Infect Dis; 2023 Jan; 23(1):81-90. PubMed ID: 36174595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine.
    Tournoy TK; Rosanas-Urgell A; Van Esbroeck M; Bottieau E; Huits R
    Int J Infect Dis; 2022 Jun; 119():56-58. PubMed ID: 35358721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have You Heard the News? Artemether-lumefantrine is Now Recommended for ALL Uncomplicated Malaria in the United States, Including in Pregnancy.
    Castro L; Ridpath A; Mace K; Gutman JR
    Clin Infect Dis; 2024 Feb; 78(2):245-247. PubMed ID: 37847222
    [No Abstract]   [Full Text] [Related]  

  • 6. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia.
    Maude RJ; Tripura R; Ean M; Sokha M; Peto TJ; Callery JJ; Imwong M; Vongpromek R; Tarning J; Mukaka M; Waithira N; Soviet O; von Seidlein L; Sovannaroth S
    BMJ Open; 2021 Jul; 11(7):e045900. PubMed ID: 34233975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
    Yeka A; Dorsey G; Kamya MR; Talisuna A; Lugemwa M; Rwakimari JB; Staedke SG; Rosenthal PJ; Wabwire-Mangen F; Bukirwa H
    PLoS One; 2008 Jun; 3(6):e2390. PubMed ID: 18545692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
    Kloprogge F; Workman L; Borrmann S; Tékété M; Lefèvre G; Hamed K; Piola P; Ursing J; Kofoed PE; Mårtensson A; Ngasala B; Björkman A; Ashton M; Friberg Hietala S; Aweeka F; Parikh S; Mwai L; Davis TME; Karunajeewa H; Salman S; Checchi F; Fogg C; Newton PN; Mayxay M; Deloron P; Faucher JF; Nosten F; Ashley EA; McGready R; van Vugt M; Proux S; Price RN; Karbwang J; Ezzet F; Bakshi R; Stepniewska K; White NJ; Guerin PJ; Barnes KI; Tarning J
    PLoS Med; 2018 Jun; 15(6):e1002579. PubMed ID: 29894518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
    Laman M; Moore BR; Benjamin JM; Yadi G; Bona C; Warrel J; Kattenberg JH; Koleala T; Manning L; Kasian B; Robinson LJ; Sambale N; Lorry L; Karl S; Davis WA; Rosanas-Urgell A; Mueller I; Siba PM; Betuela I; Davis TM
    PLoS Med; 2014 Dec; 11(12):e1001773. PubMed ID: 25549086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania.
    Marwa KJ; Liwa AC; Konje ET; Mwita S; Kamugisha E; Swedberg G
    Int J Infect Dis; 2022 Oct; 123():192-199. PubMed ID: 36064162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
    Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
    BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-related malaria treatment failure with artemether-lumefantrine.
    Halani S; Bogoch II
    J Travel Med; 2023 May; 30(3):. PubMed ID: 36951994
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
    McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
    PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.
    Achan J; Tibenderana JK; Kyabayinze D; Wabwire Mangen F; Kamya MR; Dorsey G; D'Alessandro U; Rosenthal PJ; Talisuna AO
    BMJ; 2009 Jul; 339():b2763. PubMed ID: 19622553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.
    Bassat Q; Ogutu B; Djimde A; Stricker K; Hamed K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4366-74. PubMed ID: 26014953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania.
    Joseph D; Kabanywanyi AM; Hulser R; Premji Z; Minzi OM; Mugittu K
    Malar J; 2013 Feb; 12():60. PubMed ID: 23399782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.
    Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Dhorda M; Boum Y; Sundaygar T; Zolia YM; Jones JJ; Comte E; Houzé P; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ
    Malar J; 2013 Jul; 12():251. PubMed ID: 23866774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.